Gal-3 is stimulated by gain-of-function p53 mutations and modulates chemoresistance in anaplastic thyroid carcinomas.

Source:http://linkedlifedata.com/resource/pubmed/id/19199318

Download in:

View as

General Info

PMID
19199318